Back

Prehospital risk assessment and direct transfer to a percutaneous coronary intervention centre in suspected acute coronary syndrome: 1 year follow-up of the TRIAGE-ACS study

9 March 2024 (16:44 - 16:56)
Organised by: Logo
Congress Presentation Part of: Late-breaking science Prehospital and Emergency Department Care ACVC Premium Access ESC Acute CardioVascular Care 2024 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Mr Jesse Demandt

Catharina Hospital, Eindhoven (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
The basal level of inflammation during cardiogenic shock is a strong independent risk marker of mortality.
Professor F. Roubille (Montpellier, FR)
Slides Video
Presentation thumbnail
Dual antiplatelet therapy versus oral anticoagulation plus antiplatelet monotherapy in patients with acute coronary syndrome and coronary artery ectasia: OVER-TIME randomized clinical trial
Doctor D. Araiza Garaygordobil (Ciudad de Mexico, MX)
Slides Video
Presentation thumbnail
Early left ventricular unloading or conventional approach after venoarterial extracorporeal membrane oxygenation: One-year outcomes of the EARLY-UNLOAD randomized clinical trial
Assistant Professor Y. Lim (Gwangju, KR)
Slides Video
Presentation thumbnail
Targeted mild hypercapnia is associated with reduced hs-Troponin T release after acute myocardial infarction and out-of-hospital cardiac arrest. A sub-study of the TAME trial.
Doctor M. Baumann Melberg (Oslo, NO)
Slides Video

Access the full session

Session thumbnail
Late-breaking science

The Event

Event poster

ESC Acute CardioVascular Care 2024

9 March 2024 16:44 CET
You may be interested in
thumbnail
Congress Presentation
Functional improvement of non-infarct related coronary artery stenosis by extensive LDL-C reduction with a PCSK9 antibody: the FITTER trial, microvascular function analysis
thumbnail
Congress Presentation
MACROS-2: RCT of ESC 0/1 versus 0/3 hour ADP for suspected ACS
thumbnail
Congress Presentation
Cost-effectiveness and safety of the CADScorSystem in patients with symptoms suggestive of stable coronary artery disease.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources